Insights
News, Technical Notes, Videos and more.
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Bedfordshire, UK, 1 May 2025: Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced the appointment of Dr. Jason Slingsby MBA as Chief…
Learn moreTechnical posters
Development of VSV-G Smart Polymers for Lentivirus Quantification:…
Affinity enrichment and femtomole detection of spike protein…
Developing new tools for rapid quantification of viral…
Novel synthetic affinity reagents for lentivirus analytics and…
Newsroom
NEWS
Tozaro appoints Dr. Jason Slingsby MBA as CEO…
NEWS
MIP Discovery rebrands as Tozaro as it completes…
NEWS
Tozaro closes £7M Series A financing to drive…
NEWS
Tozaro (formally MIP Discovery) secures significant funding to…
Research
Affinity enrichment and femtomole detection of spike protein…
This research poster LC-MS Detection of SARS-Cov2 Spike Protein using Smart Polymers emphasises the possibility of using smart polymers for viral purification. Download the full poster
Learn more
Development of VSV-G Smart Polymers for Lentivirus Quantification:…
3 new prototypes for the detection of in-tact lentivirus were made and evaluated in just 4 months. This shows that Tozaro’s smart polymer development process can…
Learn more
Research
Novel synthetic affinity reagents for lentivirus analytics and…
First presented at The Bioprocessing Summit 2024, this poster introduces a new suite of synthetic affinity reagents targeting VSV-G, a lentivirus envelope protein for viral vector…
Learn more
RESEARCH
Developing new tools for rapid quantification of viral…
In this poster, first presented at Advanced Therapies 2024, we introduce a process to design, develop and manufacture smart polymers, exemplified with gp120 (HIV virus envelope…
Learn more
